| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |